Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-05-03
2005-05-03
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S217090, C514S326000, C514S383000, C514S397000, C540S612000, C540S603000, C546S210000, C548S265800
Reexamination Certificate
active
06887865
ABSTRACT:
N-Heterocyclic derivatives of the formula (I):are described herein, as well as other N-heterocycles, as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using these compounds as inhibitors of nitric oxide synthase and processes for synthesizing these compounds are also described herein.
REFERENCES:
patent: 5244865 (1993-09-01), Seitz et al.
patent: 5426110 (1995-06-01), Gossett et al.
patent: 5489591 (1996-02-01), Kobayashi et al.
patent: 5663334 (1997-09-01), Sheldrake et al.
patent: 6172005 (2001-01-01), Selby
patent: 20020010190 (2002-01-01), Davey et al
patent: 0 257 850 (1988-03-01), None
patent: 0 640 599 (1995-03-01), None
patent: WO9614842 (1996-05-01), None
patent: WO9614844 (1996-05-01), None
patent: WO9809960 (1998-03-01), None
Teuber et al., Chemical Abstracts, vol. 126:18875, 1996.*
Axelsson et al., Chemical Abstracts, vol. 122:31527, 1995.*
Sakamoto et al., vol. 120:217730, 1994.*
Feldman et al., “The Surprising Life of Nitric Oxide”,Chemical and Engineering News(1993) 26-38.
Del Corona et al., “Synthesis and in vitro study of platelet antiaggregant activity of 2(4)-imidazol-1-yl-4(2)-cycloalkylaminopyrimidines”,Eur. J. Med. Chem. (1991) 26(7):729-733.
Fujisawa et al., “Inducible Nitric Oxide Synthase in a Human Glloblastoma Cell Line”,J. Neurochem.(1995) 64(1): 85-91.
Damiani et al., “Fluormetric Determination of Nitrite”Talanta(1986)33(8): 649-652.
Nathan, “Nitric oxide as a secretory product of mammalian cells”,FASEB Journal(1992) 6:3052:3064.
Lampe et al., “A Novel Rearrangement of 1-(2-Aminoaryl)imidazoles”,J. Heterocyclic Chem(1994) 31:287-291.
Arnaiz Damian O.
Baldwin John J.
Davey David D.
Devlin James J.
Dolle, III Roland Ellwood
Berlex Laboratories Inc.
Hermenau Ronald S.
Miyamoto Neil G.
Pharmacopeia Drug Discovery Inc.
Raymond Richard L.
LandOfFree
N-heterocyclic derivatives as NOS inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-heterocyclic derivatives as NOS inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-heterocyclic derivatives as NOS inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3443050